Why the study?
Does radiofrequency ablation reduce the cumulative burden of atrial fibrillation in patients with paroxysmal atrial fibrillation compared to antiarrhythmic drug therapy?
Does radiofrequency ablation reduce the cumulative burden of atrial fibrillation in patients with paroxysmal atrial fibrillation compared to antiarrhythmic drug therapy?
Radiofrequency ablation as initial therapy does not significantly reduce the 2-year cumulative burden of atrial fibrillation compared to antiarrhythmic drugs in patients with paroxysmal atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Initial ablation offers no AF burden reduction advantage over drugs; challenges preference for early ablation in paroxysmal AF.
Nielsen et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: